Healing of Erosive Disease in Multicentric Reticulohistiocytosis

REFERENCES

1. 1.↵
   1. Kovach BT,
   2. Calamia KT,
   3. Walsh JS,
   4. Ginsburg WW

   . Treatment of multicentric reticulohistiocytosis with etanercept. Arch Dermatol 2004;140:919–21.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Adamopoulos IE,
   2. Wordsworth PB,
   3. Edwards JR,
   4. Ferguson DJ,
   5. Athanasou NA

   . Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis. Hum Pathol 2006;37:1176–85.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Gorman JD,
   2. Danning C,
   3. Schumacher HR,
   4. Klippel JH,
   5. Davis JC Jr

   . Multicentric reticulohistiocytosis: case report with immunohistochemical analysis and literature review. Arthritis Rheum 2000;43:930–8.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Matejicka C,
   2. Morgan GJ,
   3. Schlegelmilch JG

   . Multicentric reticulohistiocytosis treated successfully with an anti-tumor necrosis factor agent: comment on the article by Gorman et al. Arthritis Rheum 2003;48:864–6.

   OpenUrlPubMed
5. 5.↵
   1. Partsch G,
   2. Steiner G,
   3. Leeb BF,
   4. Dunky A,
   5. Broll H,
   6. Smolen JS

   . Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J Rheumatol 1997;24:518–23.

   OpenUrlPubMed
6. 6.↵
   1. Finckh A,
   2. Simard JF,
   3. Duryea J,
   4. Liang MH,
   5. Huang J,
   6. Daneel S,
   7. et al.

   The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study. Arthritis Rheum 2006;54:54–9.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Mavragani CP,
   2. Batziou K,
   3. Aroni K,
   4. Pikazis D,
   5. Manoussakis MN

   . Alleviation of polyarticular syndrome in multicentric reticulohistiocytosis with intravenous zoledronate. Ann Rheum Dis 2005;64:1521–2.

   OpenUrlFREE Full Text
8. 8.↵
   1. Goto H,
   2. Inaba M,
   3. Kobayashi K,
   4. Imanishi Y,
   5. Kumeda Y,
   6. Inui K,
   7. et al.

   Successful treatment of multicentric reticulohistiocytosis with alendronate: evidence for a direct effect of bisphosphonate on histiocytes. Arthritis Rheum 2003;48:3538–41.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Codriansky KA,
   2. Runger TM,
   3. Bhawan J,
   4. Kantarci A,
   5. Kissin EY

   . Multicentric reticulohistiocytosis: a systemic osteoclastic disease? Arthritis Rheum 2008;59:444–8.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Jarrett SJ,
    2. Conaghan PG,
    3. Sloan VS,
    4. Papanastasiou P,
    5. Ortmann CE,
    6. O’Connor PJ,
    7. et al.

    Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum 2006;54:1410–4.

    OpenUrlCrossRefPubMed